ArticleThe journal of nutrition, health & aging2026
Divergent amino acid profiles in sarcopenic obesity versus non-obese sarcopenia: A prospective cohort study in community-dwelling older adults.
Article in The journal of nutrition, health & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe roles of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) in sarcopenia remain conflicting, largely due to the overlooked impact of obesity. Whether these AAs differentially associate with sarcopenia without obesity (sarcopenia-only) versus sarcopenic obesity (SO) is unknown. This study evaluated their cross-sectional and prospective associations and explored dietary determinants.
methodsThis prospective study included 2994 community-dwelling Chinese older adults. Serum BCAAs and AAAs were quantified at baseline. Multivariable multinomial logistic regression examined cross-sectional (baseline and 14-year) and exploratory prospective (4-year and 14-year) associations with incident sarcopenia-only and SO. Dietary intake was assessed using a validated food frequency questionnaire.
resultsCross-sectionally, each 1‑SD increment in BCAAs and AAAs was associated with lower sarcopenia-only risk (all ORs < 1, P < 0.05), whereas higher valine (OR = 1.195, P = 0.032) and isoleucine (OR = 1.221, P = 0.016) were associated with increased SO risk. The 14‑year cross‑sectional analysis confirmed the positive association between BCAAs and SO (ORs: 1.604-1.668, all P < 0.01). Prospectively over 4 years, higher baseline BCAAs and tyrosine were associated with lower sarcopenia-only risk (all ORs < 1, P < 0.05). Conversely, higher baseline isoleucine and phenylalanine emerged as short-term risk factors for incident SO (ORs: 1.233-1.331, P < 0.05). Exploratory 14‑year analyses showed directionally consistent associations, with valine inversely associated with sarcopenia‑only (OR = 0.628, P = 0.024) and BCAAs positively associated with SO (ORs: 1.555-1.693, P < 0.01). Dietary patterns differed, with sarcopenia-only showing lower fiber/vegetable intake but higher red/processed meat consumption (all P < 0.05), whereas SO showed elevated hs‑CRP (P < 0.05) and tended to have a higher dietary inflammatory index.
conclusionsIn community‑dwelling older adults, serum BCAAs and AAAs were inversely associated with sarcopenia-only but positively associated with SO. The consistency of these associations across time points supports their utility as potential concurrent metabolic markers for phenotype differentiation. These distinct profiles, alongside dietary correlates, caution against uniform AA supplementation and suggest phenotype-specific nutritional strategies in older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.